Drug Type Small molecule drug |
Synonyms Compound 1(Emory University) |
Target |
Action agonists |
Mechanism NPRA agonists(Natriuretic peptide receptor 1 agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Molecular FormulaC36H48FN7O2 |
InChIKeyHZNCLRSPHNEMRM-TXCHFRMBSA-N |
CAS Registry3055143-19-3 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Hypertension | Discovery | United States | 23 Jan 2025 |





